Wave Life Sciences Earnings
NASDAQ: WVEHealthcareBiotechnologyUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Mon, Nov 9, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.33
Wave Life Sciences earnings summary
Wave Life Sciences is scheduled to report Sep/2026 earnings on Nov 9, 2026, with analysts expecting EPS of $-0.33. In its most recent report on Jul 30, 2026 (Q2 2026), WVE posted EPS of $-0.34. Revenue for the quarter was $2.3 million.
Across the last 16 reports, WVE shares moved an average of 6.3% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
WVE earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 30, 2026 | — | $-0.34 | — | +10.7% |
| Apr 28, 2026 | — | $-0.13 | — | -1.9% |
| Jan 12, 2026 | — | $-0.29 | — | -1.3% |
| Nov 10, 2025 | — | $-0.32 | — | -0.4% |
| Jul 30, 2025 | — | $-0.31 | — | -6.3% |
| May 8, 2025 | — | $-0.29 | — | -3.9% |
| Mar 4, 2025 | — | $0.26 | — | +8.7% |
| Nov 12, 2024 | — | $-0.47 | — | +4.4% |
| Aug 8, 2024 | — | $-0.25 | — | +5.0% |
| May 10, 2024 | — | $-0.24 | — | +11.4% |
| Mar 6, 2024 | — | $-0.14 | — | -4.1% |
| Nov 9, 2023 | — | $0.07 | — | +5.0% |
| Aug 3, 2023 | — | $-0.20 | — | -5.8% |
| May 3, 2023 | — | $-0.27 | — | -0.5% |
| Mar 23, 2023 | — | $-0.39 | — | +20.9% |
| Nov 10, 2022 | — | $-0.42 | — | +9.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.